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Abstract
One of the key mechanisms involved in sympathoexcitation in chronic heart failure 
(HF) is the activation of the adrenal glands. Impact of the elevated catecholamines on 
the hemodynamic parameters has been previously demonstrated. However, studies 
linking the structural effects of such overactivation with secretory performance and cell 
metabolism in the adrenomedullary chromaffin cells in vivo have not been previously 
reported. In this study, HF was induced in male Sprague-Dawley rats by ligation of 
the left coronary artery. Five weeks after surgery, cardiac function was assessed by 
ventricular hemodynamics. HF rats showed increased adrenal weight and adrenal 
catecholamine levels (norepinephrine, epinephrine and dopamine) compared with 
sham-operated rats. Rats with HF demonstrated increased small synaptic and dense 
core vesicle in splanchnic–adrenal synapses indicating trans-synaptic activation of 
catecholamine biosynthetic enzymes, increased endoplasmic reticulum and Golgi lumen 
width to meet the demand of increased catecholamine synthesis and release, and more 
mitochondria with dilated cristae and glycogen to accommodate for the increased 
energy demand for the increased biogenesis and exocytosis of catecholamines from the 
adrenal medulla. These findings suggest that increased trans-synaptic activation of the 
chromaffin cells within the adrenal medulla may lead to increased catecholamines in the 
circulation which in turn contributes to the enhanced neurohumoral drive, providing 
a unique mechanistic insight for enhanced catecholamine levels in plasma commonly 
observed in chronic HF condition.
Introduction
Enhanced neurohumoral drive is a major risk factor 
that influences the progression of chronic heart failure 
(HF) and mortality in patients and the experimental 
models (Packer 1988, Zucker et al. 1995, Patel 1997). 
During HF, enhanced levels of catecholamines resulting 
from activation of the sympathetic nervous system 
ensure an increase in cardiac function, to achieve an 
adaptation of the cardiac output to the systemic needs. 
However, long-term stimulation of catecholamines 
becomes harmful, contributing to the progression of HF. 
Although most therapeutic pharmaceutical strategies 
target the peripheral symptoms of the disease, they may 
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not influence the enhanced sympathetic nerve activity. 
Indeed, various studies have detailed the role of cardiac 
and hemodynamic mechanisms involved in the elevated 
sympathetic drive in HF (Packer 1988, Ferguson et al. 1990, 
Brändle et al. 1996, Patel 1997). The role of the adrenal 
gland in the development of sympathetic overactivation 
and progression of HF is less well known.
Circulating catecholamines, comprising dopamine 
(DA), norepinephrine (NE) and epinephrine (EPI), are 
primarily synthesized and released from the chromaffin 
cells of the adrenal medulla (Goldstein et al. 2003). 
Under physiological (nonstress) conditions, the adrenal 
medulla secretes ~80% of EPI and ~20% of NE (Tank & 
Lee Wong 2015). While EPI is secreted exclusively from 
the adrenal medulla, the major source of circulating 
NE is from sympathetic nerve endings (Goldstein et al. 
2003). Plasma DA comes from the adrenal medulla, 
sympathetic nerve endings and the brain. Resting levels 
of plasma catecholamines range from 25 to 70 pg/mL 
for DA, 200 to 300 pg/mL for NE and 30 to 70 pg/mL 
for EPI (Tank & Lee Wong 2015). Although plasma DA 
concentration is similar to those of EPI, circulating DA 
does not act as a hormone because of its much lower 
potency. Plasma concentrations of NE and EPI increase 
dramatically in response to physical, psychological 
or environmental stress, exercise, exposure to cold 
or low oxygen tension or fear and alarm to counteract 
with the stress (Tank & Lee Wong 2015). This biological 
response of catecholamines is considered as an 
adaptive response.
The contribution of adrenal catecholamines to 
the progression of HF has been documented in a few 
experimental models (Lymperopoulos et al. 2010, 
Schneider et al. 2011). Adrenal gland hypertrophy has 
been reported in rats after experimental myocardial 
infarction (Schneider et  al. 2011). Mice lacking  
α2C-adrenoceptors which control EPI secretion in 
adrenal chromaffin cells show rapid deterioration of 
cardiac function and raised mortality after transverse 
aortic constriction (de Lucia et al. 2014). Interestingly, 
reduction in sympathetic activity via adrenal-targeted 
G-protein-coupled receptor kinase 2 (GRK2) gene 
deletion attenuates HF progression and improves cardiac 
function after myocardial infarction (Lymperopoulos 
et  al. 2010). Therapeutic strategies such as β-blocker 
and exercise training have been reported to improve 
outcome in HF, likely by lowering HF-dependent 
sympathetic nervous system hyperactivity, and at 
least in part, via reduction in adrenal catecholamine 
hypersecretion (Rengo et al. 2010, de Lucia et al. 2014).
Elevated levels of circulating catecholamines have 
been reported in both patients with HF and animals 
with experimental HF (Cohn et al. 1984, Kleiber et al. 
2008). Under the stress condition, the increase in plasma 
EPI is derived almost completely from the adrenal 
medulla, whereas about 70% plasma NE is derived from 
sympathetic nerves (Kvetnansky et al. 1979). Exaggerated 
sympathetic nerve activation is a major risk factor 
that influences the progression of HF and mortality in 
patients. High levels of plasma NE in patients with HF 
have been known to have very poor prognosis (Cohn 
et  al. 1984). Although most therapeutic pharmaceutical 
strategies target the peripheral symptoms of the disease, 
they may not influence the overall enhanced sympathetic 
activation. Reducing the adrenergic drive is important, as 
HF patients with lower levels of plasma NE are given a 
better prognosis (Cohn et al. 1984). However, the adrenal 
medullary contribution and alterations for the origin of 
catecholamines in the circulation during HF condition 
are not fully explored to date. Thus, we hypothesized 
that the structural effects of secretory performance and 
cell metabolism in the adrenal medullary chromaffin cells 
may lead to increased catecholamines in the circulation 
which in turn contributes to the enhanced neurohumoral 
drive commonly observed in the HF condition.
Materials and methods
Study approval
All the procedures on animals in this study were approved 
by the University of Nebraska Medical Center Institutional 
Animal Care and Use Committee. The experiments were 
conducted according to the American Physiological 
Society guiding principles for research involving animals 
and human beings and the NIH guide for the care and use 
of laboratory animals.
Induction of heart failure
Male Sprague-Dawley rats weighing 200–220 g were 
obtained from Sasco Breeding Laboratories (Omaha, NE, 
USA) and were randomly assigned to a sham-operated 
group and an HF group. HF was produced by coronary 
artery ligation, as described previously (Zhang et al. 2001, 
Kleiber et al. 2008). Each rat was caged individually in an 
environment with ambient temperature maintained at 
22°C and humidity at 30–40%. Laboratory chow and tap 
water were available ad libitum.
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The degree of left ventricular dysfunction and HF 
were determined using both hemodynamic and anatomic 
criteria. Echocardiograms were performed at 5 weeks after 
surgery. Left ventricular end-diastolic pressure (LVEDP) was 
measured using a Mikro-Tip catheter (Millar Instruments, 
Houston, TX, USA) at the time of the terminal experiment. 
To measure infarct size, the heart was dissected and the 
atria and right ventricle were removed. A digital image 
of the left ventricle was captured using a digital camera. 
The percentage of infarct area to total left ventricle area 
was quantified using SigmaScan Pro (Aspire Software 
International, Ashburn, VA, USA). Rats with both LVEDP 
> 15 mmHg and infarct size > 30% of total left ventricular 
wall were considered to be in HF. Sham-operated rats were 
treated similarly as the HF rats except that their coronary 
arteries were not ligated.
Adrenal catecholamine measurements
The adrenal glands were harvested from each animal 
immediately after killing. These samples were weighed, 
homogenized in cold perchloric acid containing 
ethylenediaminetetraacetic acid and centrifuged at 4°C 
for 15 min at 15,000 g. The supernatants were stored 
at −70°C until they were assayed for catecholamines. 
DA, NE and EPI concentrations were assayed using alumina 
extraction followed by separation and analysis with HPLC 
and electrochemical detection (Bioanalytical Systems, 
West Lafayette, IN, USA). Dihydroxybenzylamine (Sigma) 
was used as an internal standard in each tissue sample 
(Kline et al. 1986).
Urinary norepinephrine excretion measurement
Urinary NE excretion was measured as an index of overall 
sympathetic activation. Five weeks after surgery, rats from 
all groups were placed in metabolic cages and urine was 
collected for 24 h. Urinary NE concentration of thawed 
samples was measured using a commercially available 
ELISA kit (Labor Diagnostika Nord, Nordhorn, Germany), 
following the manufacturer’s instructions.
Real-time RT-PCR and Western blot measurement  
of catecholamine biosynthetic enzymes in the  
adrenal gland
The half adrenal gland was placed in 500 μL Tri-Reagent 
(Molecular Research Center Inc, OH, USA), followed by 
extraction of mRNA. The other half of adrenal gland 
Table 1 Primer sequences used for quantitative real-time 
PCR analysis.
Gene Primer sequence
TH Sense: CTGGGTGCACTTGTCTGTGCAGT
Antisense: CAGTACACCGTGGAGAG
DβH Sense: CACCACATCATCATGTATGAGG
Antisense: CCTGTCTGTGCAGTAGCCAG
PNMT Sense: TACCTCCGCAACAACTACGC
Antisense: AAGGCTCCTGGTTCCTCTCG
GAPDH Sense: TGACAACTCCCTCAAGATTTGTCA
Antisense: GGCATGGACTGTGGTCATGA
Table 2 The characteristics of sham and HF rats.
Measures Sham HF
Body weight (g) 416 ± 14 457 ± 13*
Heart weight (g) 1.2 ± 0.1 2.4 ± 0.2*
Infarct size (% of epicardial LV) 0 34 ± 2*
LVEDP (mmHg) 2 ± 1 24 ± 5*
Ejection fraction, % 81 ± 5 51 ± 5*
dP/dt, mmHg/s 8549 ± 663 5102 ± 364*
−dP/dt, mmHg/s −6836 ± 346 −4637 ± 298*
Values are mean ± s.e. *P < 0.05 versus sham; n = 8/group. LV left ventricle, 
LVEDP left ventricular end-diastolic pressure.
Figure 1
A representative image of the left ventricle from 
one sham and one HF rat. Circled area indicates 
infarcted area of the heart in the HF rat. There 
was no such area in the sham rat. A full colour 
version of this figure is available at http://dx.doi.
org/10.1530/JOE-16-0146.
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was placed in 150 μL RIPA lysis buffer to extract the 
protein. Real-time RT-PCR measurements were made with 
the iCycler iQ Multicolor Real-Time Detection System 
(Bio-Rad). The reaction mixture consisted of SYBR Green 
Supermix (Bio-Rad), 300 nM sense and antisense primers, 
and the cDNA template of interest (for primer sequences 
see Table 1). Relative expression of tyrosine hydroxylase 
(TH, the rate limiting enzyme in catecholamine 
biosynthesis, which converts tyrosine to l-Dopa), 
dopamine-β-hydroxylase (DβH, which converts dopamine 
to NE) and phenylethanolamine N-methyltransferase 
(PNMT, which converts NE to EPI) mRNA was calculated 
with the Pfaffl equation, which relates the expression 
of the target gene to the expression of reference gene: 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH).
The protein samples were loaded onto an SDS-
PAGE gel and subjected to electrophoresis. The 
fractionated proteins on the gel were transferred to a 
polyvinylidene difluoride membrane (Millipore). The 
membrane was probed with primary antibody (rabbit 
anti-TH (1:500), DβH (1:500) and PNMT (1:1000) 
(Abcam) or mouse anti-β-actin (1:1000, Santa Cruz)) 
overnight, and then probed with secondary antibody 
(peroxidase-conjugated anti-rabbit or goat IgG, 1:5000, 
Pierce). An enhanced chemiluminescence substrate 
(Pierce) was applied to the membrane, followed by an 
exposure within an UVP system (UVP BioImaging, CA, 
USA) for visualization. Kodak 1D software (Kodak) was 
used to quantify the signal. The expression of protein 
was calculated as the ratio of intensity of the TH, DβH 
and PNMT bands, respectively, relative to the intensity 
of β-actin band.
Transmission electron microscopy (TEM)
Five weeks after surgery, rats were anesthetized 
with pentobarbital (150 mg/kg, i.p.) and perfused 
transcardially with Ca2+- and Mg2+-free buffer composed 
of Dulbecco’s phosphate-buffered saline, 10 mM 
HEPES, 0.2 mM ethylene glycol tetraacetic acid, 0.2% 
bovine serum albumin, 5 mM glucose and 9.5 mM KCl 
following the fixative containing 2.5% glutaraldehyde, 
2% paraformaldehyde in 0.15 M cacodylate buffer as 
described previously (Pasqua et al. 2016). The adrenal 
gland was removed, sliced into small pieces and postfixed 
in the same fixative at 4°C overnight. The adrenal slices 
were stained en bloc with 2–3% uranyl acetate for 1 h on 
ice, dehydrated in graded series of ethanol (20–100%) 
on ice followed by one wash with 100% ethanol and 
two washes with acetone (15 min each) and embedded 
with Durcupan. Sections (50–60 nm thick) were cut on 
a Leica UCT ultramicrotome, picked up on Formvar and 
carbon-coated copper grids, and stained with 2% uranyl 
acetate for 5 min and Sato’s lead stain for 1 min. Grids 
were viewed using a JEOL 1200EX II (JEOL, Peabody, 
MA, USA) TEM and photographed using a Gatan digital 
camera (Gatan, Pleasanton, CA, USA). Micrographs were 
randomly taken from three adrenal glands each from 
sham and HF rats.
Figure 2
Gravimetry and catecholamine content in sham-operated and HF rats.  
(A) Weight of the adrenal gland (mg). (B) Adrenal NE content.  
(C) Adrenal EPI content. (D) Adrenal dopamine (DA) content. (E) Urinary 
NE level. *P < 0.05; **P < 0.01.
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Morphometric analysis
Samples were blinded and two people did measurements 
randomly from different cells. The line segment tool in 
ImageJ was used to measure diameters (large dense core 
vesicle-LDCV, small dense core vesicle-SDCV and small 
synaptic vesicle-SSV), length (mitochondria) and lumen 
width (endoplasmic reticulum-ER, Golgi and  cristae). 
The free-hand tool was used to manually trace around 
the vesicle membrane (LDCV, SDCV and SSV) and 
mitochondrial outer membrane area and cytoplasm 
area. For determination of the volume density (%) of 
vesicles and mitochondria, the sum of the area of the 
vesicles or mitochondria was divided by the area of the 
cytoplasm and multiplied by 100 as described previously 
(Pasqua et al. 2016).
Figure 3
Expression of TH, DβH and PNMT in the adrenal 
glands of sham and HF rats. (A) TH, DβH and 
PNMT mRNA expressions relative to GAPDH 
measured by real-time PCR in sham and HF rats  
(B) Protein levels of TH, DβH and PNMT in sham 
and HF rats. *P < 0.05; **P < 0.01.
Figure 4
Low-magnification (×2500 original magnification) 
TEM photographs of the axon terminal. (A) Axon 
terminal in NE cells of sham-operated rat.  
(B) Axon terminal in NE cells of HF rat. 
Morphometric analyses (30 nerve terminals in  
30 chromaffin cells from 3 each of the  
sham-operated and HF rats). (C) SSV area (nm2). 
(D) SSV diameter (nm). (E) SSV per µm2 area of 
the synapse. (F) SDCV area (nm2) and SDCV 
diameter (nm). SDCV, small dense core vesicle; 
SSV, small synaptic vesicle. ***P < 0.001, #: not 
significant.
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Data presentation and statistical analysis
Data are expressed as mean ± s.e.m. Statistical analyses 
were performed using Student’s t-tests, Kolmogorov–
Smirnov test as well as one-way ANOVA followed by 
Dunnett’s post hoc test when appropriate. Statistical 
significance was defined as P < 0.05. Statistics were 
computed with the software package, Prism 7 (GraphPad 
Software, San Diego, CA, USA).
Results
General characteristics
Table 2 presents general characteristics and left ventricular 
function parameters among the experimental groups. The 
body weight and whole heart weight was significantly 
increased in HF group. Only rats with >30% infarct of the 
left ventricular wall were included in the study. Sham-
operated rats had no visible myocardial damage 
(Fig. 1). Ejection fraction was significantly lower in 
HF group. LVEDP was significantly increased in the 
HF rats compared with sham group. HF rats had 
significantly ‘lower change in pressure over time’ (+dP/dt 
and –dP/dt) compared with sham rats suggesting 
reduced contractility/relaxation. These data confirm 
that these rats in the HF groups were experiencing 
cardiac dysfunction as shown in greater detail before 
(Patel et al. 2000, Zhang et al. 2001, Kleiber et al. 2008).
Increased adrenal weight and adrenal catecholamines  
in HF rats
Consistent with prolonged stress, adrenal glands were 
heavier in HF rats compared with sham-operated rats 
Figure 5
Low-magnification (×2500 original 
magnification) TEM photographs of the adrenal 
medulla. (A) Adrenal medulla showing NE cells 
with LDCV in a sham-operated rat. (B) Adrenal 
medulla showing NE cells with LDCV in an HF rat. 
(C) Adrenal medulla showing EPI cells with LDCV 
in a sham-operated rat. (D) Adrenal medulla 
showing EPI cells with LDCV in an HF rat. 
Morphometric analyses (650 vesicles total from 3 
each of the sham-operated and HF rats):  
(E) Volume densities (%) of LDCV. (F) Number of 
LDCVs per µm2 area of the cytoplasm. (G) Vesicle 
area (nm2) of NE-LDCV and EPI-LDCV. (H) LDCV 
diameter (nm) in NE-LDCV and EPI-LDCV. 
*P < 0.05; **P < 0.01; ***P < 0.001 and #: not 
significant.
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(26.7 ± 5.3 HF vs 12.5 ± 1.3 mg sham, P < 0.05) (Fig. 2A). 
Likewise, catecholamine (NE, EPI and DA) contents in 
the adrenal glands (Fig. 2B–D) were higher in HF rats 
compared with sham-operated rats. Adrenal NE content 
was significantly greater in HF rats compared with 
sham-operated controls (325 ± 35 vs 168 ± 36 ng/mg, 
P < 0.05). Adrenal EPI was 404 ± 63 HF vs 202 ± 41 ng/mg 
sham (P < 0.05). Adrenal DA was 46 ± 12 HF vs 18 ± 2 μg/g 
sham (P < 0.05).
Urinary norepinephrine excretion measurements
Urinary NE excretion was significantly greater in HF 
rats compared with sham-operated controls as an 
index of overall sympathetic activation (7.8 ± 2.3 HF vs 
3.2 ± 1.8 μg/day sham, P < 0.05) (Fig. 2E).
Increased adrenal expression of catecholamine 
biosynthetic enzymes in HF rats
Consistent with the increased adrenal catecholamine 
contents in the adrenal glands in HF rats, the trans-
synaptic induction caused significant increase in mRNA 
and protein expressions of catecholamine biosynthetic 
enzymes such as TH, DβH, and PNMT in HF rats compared 
with sham-operated rats (Fig. 3A and B). It is of particular 
note that there was more than 30-fold increase in the 
message for PNMT in HF rats.
Figure 6
High magnification (×15,000 original 
magnification) TEM photographs of the adrenal 
medulla. (A) Adrenal medulla showing NE cells 
with LDCV in a sham-operated rat. (B) Adrenal 
medulla showing NE cells with LDCV in an HF rat. 
(C) Adrenal medulla showing EPI cells with LDCV 
in a sham-operated rat. (D) Adrenal medulla 
showing EPI cells with LDCV in an HF rat. 
Morphometric analyses were carried out in  
650 vesicles total from 3 each of the sham-
operated and HF rats. Relative frequency 
distribution of NE-LDCV diameter (E) and 
EPI-LDCV diameter (F) are shown. Note highly 
significant (P < 0.0001) right shift in the 
distribution of NE and EPI vesicular diameter with 
heart failure.
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Splanchnic nerve terminal and synaptic vesicles
The splanchnic–adrenal synapse contains two types of 
vesicles: clear SSV (presumably cholinergic) and SDCV 
(presumably peptidergic) (Coupland 1965, Smith & 
Eiden 2012). In sham-operated rats, we observed SSV in 
the splanchnic–adrenal synapse (Fig. 4). However, in rats 
with HF, we found SSV and SDCV in the splanchnic–
adrenal synapse. In addition to SDCV, we found significant 
increased SSV in HF rats.
Increased volume density, vesicle area and vesicle 
diameter of NE and EPI granules in HF rats
As shown previously in mouse adrenal medulla (Pasqua 
et al. 2016), the NE-storing vesicles in rats were characterized 
by typical intensely electron-dense granules, some of which 
displaying a flattened or tubular appearance (Fig. 5A and B). 
In contrast, the EPI-storing vesicles were moderately 
electron dense and smaller in size (Fig. 5C and D). Although 
there were no changes in numerical density of the LDCV 
in chromaffin cells between sham-operated and HF rats 
(Fig. 5F), HF rats displayed increased LDCV volume density 
(Fig. 5E) coupled with increased LDCV area (Fig. 5G) and 
LDCV diameter (Fig. 5H) compared with sham-operated rats. 
Relative frequency distribution of NE-LDCV and  
EPI-LDCV in sham and HF rats
While 100–250 nm LDCV diameters of NE-storing cells 
predominate in sham-operated rats, the preponderant 
Figure 7
High magnification (×15,000 original 
magnification) TEM photographs of rough 
endoplasmic reticulum (RER). (A) NE cells showing 
RER and LDCV in a sham-operated rat. (B) NE cells 
showing RER (dilated) and LDCV in an HF rat.  
(C) EPI cells showing RER and LDCV in a  
sham-operated rat. (D) EPI cells showing RER 
(dilated) and LDCV in an HF rat. Morphometric 
analyses (2 RER per chromaffin cell for a total of  
60 RER in 30 cells from 3 each of the  
sham-operated and HF rats). (E) Average ER lumen 
width (nm). (F) Average ribosomes per 100 nm 
length of ER. ***P < 0.001; # not significant.
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LDCV diameters in HF rats ranged from 250 to 400 nm 
(Fig. 6A, B and E). Kolmogorov–Smirnov test revealed 
highly significant right shift in the distribution of 
vesicular diameter with heart failure (Kolmogorov–
Smirnov D = 0.29; P < 0.0001). Similarly, LDCV 
diameters in EPI-storing vesicles were higher in HF 
rats (200–300 nm) compared with sham-operated 
rats (Fig. 6C, D and F). Like NE vesicles, there was a 
significant right-ward shift in the distribution of 
EPI vesicular diameters in rats with heart failure as 
evaluated by Kolmogorov–Smirnov test (Kolmogorov–
Smirnov D = 0.36; P < 0.0001).
Rough endoplasmic reticulum (RER) and  
Golgi complex (GC)
ER regulates the synthesis, folding and maturation of 
secreted and transmembrane proteins and the storage 
of Ca2+, lipid biosynthesis and redox homeostasis 
(Oakes & Papa 2015). Since HF rats suffer from prolonged 
stress, the adrenal medulla synthesized and secreted more 
catecholamines compared with sham-operated rats to 
cope with the stress situation. Increased catecholamine 
synthesis requires increased synthesis of catecholamine 
biosynthetic enzymes. Consistent with the above, HF 
rats displayed increased RER lumen width in both NE 
Figure 8
High-magnification (×15,000 original 
magnification) TEM photographs of Golgi 
complex (GC). (A) NE cells showing GC and LDCV 
in a sham-operated rat. (B) NE cells showing GC 
(dilated) and ISG in an HF rat. (C) EPI cells 
showing GC and LDCV in a sham-operated rat. 
(D) EPI cells showing GC (dilated) and LDCV in an 
HF rat. Morphometric analyses (1 GC per 
chromaffin cell for a total of 60 GC from 3 each 
of the sham-operated and HF rats). (E) Average 
GC lumen width. CV, cis-Golgi vesicles; ISG, 
immature secretory granule; TV, trans-Golgi 
vesicle; SC, stacked-Golgi cisternae. ***P < 0.001.
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and EPI storing cells compared with sham-operated 
rats (Fig. 7A–E). Surprisingly, ribosomal numerical 
density did not change between HF and sham-operated 
rats (Fig. 7F).
GC is the site of processing, packaging and sorting 
of proteins and lipids en route from the ER to the plasma 
membrane and other destinations (Sengupta & Linstedt 
2011). Increased catecholamine synthesis in HF rats would 
require formation of more vesicles for catecholamine 
storage. This increased workload has resulted in dilation 
of GC lumen in HF rats compared with sham-operated 
rats (Fig. 8A–E).
Figure 9
High-magnification (x15,000 original 
magnification) TEM photographs of 
mitochondria. (A) NE cells showing  
tubulo-lamellar mitochondria and LDCVs in a 
sham-operated rat. (B) NE cells showing a 
tubulo-vesicular mitochondrion and LDCVs in an 
HF rat. (C) EPI cells showing a tubulo-lamellar 
mitochondrion and LDCVs in a sham-operated 
rat. (D) EPI cells showing tubulo-vesicular 
mitochondria and LDCVs in an HF rat. 
Morphometric analyses (60 mitochondria total 
from 3 each of the sham-operated and HF rats): 
(E) Average mitochondria numbers per 10 µm2 
area of the cytoplasm. (F) Average mitochondrial 
volume density (%). (G) Average mitochondrial 
area (nm2). (H) Average mitochondrial length (nm). 
(I) Average cristae lumen width (nm). *P < 0.05; 
***P < 0.001; # not significant.
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Mitochondrial lengths, volume and numerical densities 
and cristae volume density
Mitochondria regulates the life and death of a cell 
by providing the enzymes and structural framework 
for generation of adenosine triphosphate (ATP), 
which serves as the energy currency of the cell 
(Scheffler 2008). Mitochondria in NE- and EPI-storing 
sham-operated rats showed the typical tubulo-lamellar 
appearance (Fig. 9A and C). In HF rats, mitochondrial 
cristae were dilated and looked like tubulo-vesicular 
mitochondria (Fig. 9B and D). Since increased ATP 
synthesis is required to counteract the prolonged 
stress, HF rats responded by increased biogenesis of 
mitochondria as shown by increased mitochondrial 
numerical density (Fig. 9E), which is accompanied 
by decreased mitochondrial area (Fig. 9G) and 
length (Fig. 9H). Despite increased mitochondrial 
numerical density in HF rats, there was no change in 
mitochondrial volume density (Fig. 9F) because of the 
smaller mitochondrial area (Fig. 9E–G). In addition to 
increased biogenesis of mitochondria, HF rats showed 
increased cristae lumen width to meet the increased 
energy demand in HF rats (Fig. 9I).
Changes in glycogen granules
At the ultrastructural level, glycogen appears as 
roughly circular granules from 150 to 400 Å in diameter 
(Revel et  al. 1960). Nutrient (high-fat diet) and 
hyperadrenergic (increased plasma catecholamines) 
stress appear to increase storage of glycogen for 
steady glucose supply to meet the high-energy demand 
(Pasqua et  al. 2016). Consistent with the above 
stressors, we found an increased number of glycogen 
granules in HF rats compared with sham-operated rats 
(Fig. 10A–C).
Discussion
This study provides novel electron micrographic 
evidence to characterize the fundamental changes in the 
adrenomedullary chromaffin cells related to the status 
of the sympathetic nervous system activation during 
the HF condition. First, conscious undisturbed rats with 
HF display an enhanced adrenal medullary activity 
in rats with HF. Second, SDCV (possibly containing 
pituitary adenylate cylase-activating peptide (PACAP) 
and vasoactive intestinal peptide (VIP)) in splanchnic–
adrenal synapse of HF rats aids in maintaining long-term 
catecholamine secretion using secretory mechanisms 
different from that of acetylcholine. Third, increased ER 
and Golgi lumen width in HF rats are consistent with 
the demand of increased catecholamine synthesis and 
release. Fifth, more mitochondria with dilated cristae 
suggest increased ATP production, which is required for 
increased LDCV priming and subsequent exocytosis in 
rats with HF. Sixth, increased glycogen content in HF rats 
is indicative of a metabolic switch to accommodate the 
HF-induced prolonged stress. Taken together, these data 
provide a comprehensive characterization of the adaptive 
changes indicative of increased machinery for enhanced 
adrenal activity in the adrenal medullary chromaffin 
cells to provide chronic activation of the adrenal medulla 
during the chronic HF condition.
The adrenal medulla is innervated by preganglionic 
sympathetic neurons that are located in the 
intermediolateral cell column of the thoracic spinal cord 
and extend out to the adrenal medulla through thoracic 
splanchnic nerves (Wakade 1988, Mahata et al. 2000). The 
splanchnic–adrenal synapse contains both cholinergic 
(such as acetylcholine in SSV) and peptidergic (such as 
PACAP, VIP and secretin in SDCV) neurotransmitters 
(Wakade 1988, Guo & Wakade 1994, Taupenot et al. 1998, 
Mahata et  al. 2000). While acetylcholine stimulates the 
Figure 10
High-magnification (×15,000 original magnification) TEM photographs showing glycogen granules. (A) NE cells showing glycogen granules, LDCVs and 
mitochondrion in a sham-operated rat. (B) NE cells showing glycogen granules and LDCVs in an HF rat. (C) Morphometric data (60 cells total from 3 each 
of the sham-operated and HF rats) showing number of glycogen granules per µm2 of the cytoplasm. ***P < 0.001.
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secretion of NE and EPI, PACAP and VIP predominantly 
stimulate the secretion of EPI (Guo & Wakade 1994). 
The low-frequency splanchnic nerve firing (mainly by 
acetylcholine) causes catecholamine secretion from 
the adrenal medulla at a modest rate to maintain basal 
functioning. In contrast, the high-frequency firing 
(mainly PACAP and also acetylcholine) associated with 
emergency (stress) responses induce the adrenal medulla 
to secrete catecholamines at an elevated rate to combat 
with the perceived stress situation (Smith & Eiden 2012, 
Stroth et al. 2013).
Consistent with the above findings and hypothesis, 
we found SDCV (possibly containing PACAP and VIP) in 
splanchnic–adrenal synapse of HF rats. Existing literature 
suggest that PACAP maintains long-term catecholamine 
secretion using secretory mechanisms different from that 
of acetylcholine (rapidly desensitizing) and via induction 
of the catecholamine biosynthetic enzymes such as TH, 
DβH and PNMT (Taupenot et al. 1999, Smith & Eiden 
2012, Stroth et  al. 2013). Consistent with this idea in 
fact, increased mRNA levels of TH and PNMT in HF have 
been reported previously in pig (Tomaszek et al. 2015). 
Coherent with this, in fact, the trans-synaptic induction 
caused a dramatic and significant increase in TH, DβH and 
PNMT mRNA expression as well as protein in rats with 
HF. This upregulation was likely triggered by enhanced 
sympathetic tone commonly reported in HF.
Catecholamine secretion from adrenal medullary 
chromaffin cells is influenced by both cholinergic 
and peptidergic stimuli conducted by preganglionic 
sympathetic neurons that are located in the 
intermediolateral cell column of the thoracic spinal cord 
and extend to the adrenal medulla through thoracic 
splanchnic nerves (Mirkin 1961). The splanchnic–
adrenal synapse contains two types of vesicles: clear 
SSV (presumably cholinergic) and SDCV (presumably 
peptidergic) (Coupland 1965, Smith & Eiden 2012). 
Cholinergic (acetylcholine) and peptidergic (such as 
PACAP and VIP) transmitters are preferentially released 
from this splanchnic–adrenal synapse: acetylcholine 
from SSV is released during low-frequency firing to 
release catecholamines at a modest rate for basal 
functioning; PACAP is released from SDCV along with 
acetylcholine during high-frequency firing upon stress-
induced heightened sympathetic activation and releases 
catecholamines from LDCV at a much higher rate 
to accommodate the stress situation (Smith & Eiden 
2012). In this study, we found normal levels of SSV in 
the splanchnic–adrenal synapse in sham-operated rats, 
whereas in rats with HF, we found a significant increase 
in SSV and SDCV in the splanchnic–adrenal synapse. 
These data indicate that the preganglionic sympathetic 
innervation to the adrenal medulla is primed for 
overactivation and sustained activation in rats with HF. 
It is likely that the increased SSV and SDCV aid in the 
chronic long-term activation of the adrenal medullary 
chromaffin cells in the chronic HF condition.
The body responds to stress by activating two 
hormonal systems: (1) the hypothalamus–pituitary–
adrenal (HPA) axis, which causes the release of 
corticotrophin-releasing hormone (CRH) from the 
hypothalamus, followed by adrenocorticotrophic 
hormone (ACTH) from the anterior pituitary in response 
to CRH and finally cortisol (human) or corticosterone 
(rodents) from the adrenal cortex in response to ACTH 
and (2) brainstem catecholaminergic neurons and spinal 
cord efferent activates the sympathetic nervous system 
and adrenal medulla to secrete NE (from the sympathetic 
nervous system and adrenal medulla) and EPI (from the 
adrenal medulla) (Tank & Lee Wong 2015). As shown 
previously in adrenal medulla, the NE-storing vesicles 
are typically characterized by intense electron-dense 
granules, some of which displaying a flattened or tubular 
appearance. In contrast, the EPI-storing vesicles are 
moderately electron dense and smaller in size (Pasqua 
et al. 2016). This distinction allowed us to quantify the 
changes in these two distinct types of chromaffin cells 
in rats with HF.
The stress-induced release of NE and EPI varies 
dramatically in response to various stressors. For example, 
insulin-induced hypoglycemia or 2-deoxyglucose-
induced glucoprivation causes profound release of EPI (by 
10- to 30-fold) compared with a modest release of NE (by 
twofold) (Blandini et al. 1995, Elman et al. 2001). Surgical 
stress also causes profound release of EPI (Mannelli et al. 
1982). In contrast, cold stress causes more release of NE 
than EPI (Johnson et al. 1977). Differential release of NE 
and EPI in response to different stressors has also been 
documented in animal studies (Pacak et al. 1998). In 
HF, there is general overactivation of the sympathetic 
nervous system. In mice, HF causes release of more NE (by 
7.5-fold) and EPI (by 2.8-fold) (Kamal et al. 2014). This 
is indicative of an elevated overall sympathoexcitation 
to the general circulation during HF. It is of interest to 
note that previously we have shown that CgA-deficient 
Chga-KO mice also suffer from persistent systematic stress 
due to increased secretion of catecholamines compared 
with WT mice, which leads to hypertension and also 
demonstrates majority of the morphological changes that 
are observed in the hypersympathetic state observed in 
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the HF condition in this study (Pasqua et al. 2016). This 
suggests an intriguing overarching global conclusion that 
hyperactivated sympathetic state, regardless of its initial 
cause or origin can demonstrate similar morphological 
changes in the activated adrenal glands dictating 
catecholamine synthesis, storage and release.
It should be noted that there is strong evidence 
for a regionally heterogeneous pattern of sympathetic 
activation that appears to be targeted to specific tissues in 
experimental HF. Increased NE spillover from heart and 
kidney (but not lung) (Hasking et  al. 1986, Eisenhofer 
et al. 1996, Rundqvist et al. 1997) and increased burst 
number in postganglionic sympathetic efferent to the 
vasculature of skeletal muscle (Ferguson et al. 1990) have 
been described in clinical HF. We have previously shown 
an increased turnover of NE in the heart, kidney and 
skeletal muscle, but not in spleen and liver in rats with HF 
(Patel et al. 2000). NE turnover can be influenced by any 
event that affects synthesis, release, uptake or breakdown 
of NE at the noradrenergic nerve terminal. For example, 
increased circulating or local angiotensin II levels in HF 
could stimulate NE release from peripheral sympathetic 
nerve endings (Clemson et al. 1994, Driessen & 
Starke 1994), thus promoting increased NE turnover. 
Noradrenergic processes at the level of nerve terminal 
that are independent of neural activity appear to be 
unaltered in rats with HF, which also implicates centrally 
mediated neural mechanisms in causing the regional 
increases in NE turnover. In this study, the changes in the 
adrenal medulla appear to be dictated by an overactive 
state during HF.
This study shows a significant activation of the 
adrenal medulla of rats with HF. The close parallel between 
the results of these studies and the clinical literature 
strengthens the contention that sympathetic activation 
of some (but not all) tissues accompanies HF. Our findings 
in rats are also consistent with the findings in mice, where 
more plasma catecholamines are compensated by more 
resynthesis (as evidenced by more NE and EPI in the 
adrenal gland) (Kamal et  al. 2014). We found increased 
volume density, LDCV area and LDCV diameter for both 
NE-storing cells as well as EPI-storing vesicles in HF rats 
compared with sham rats. These results indicate the 
increased machinery for enhanced adrenal activity in rats 
with HF.
The findings of increased ER (for synthesis of more 
catecholamine biosynthetic enzymes and SNARE proteins 
involved in exocytosis) and Golgi lumen (for formation of 
more catecholamine storage vesicles) width in HF rats are 
consistent with the demand of increased catecholamine 
synthesis and release. In the chronic HF condition, elevated 
plasma levels of catecholamines would require additional 
synthesis and release that perhaps are maintained by this 
increased ER in the chromaffin cells.
 The peroxisome proliferator-activated receptor-γ 
(PPARγ) coactivator 1α (PGC-1α) is a major regulator of 
exercise-induced phenotypic adaptation and substrate 
utilization. A modest (~25%) upregulation of PGC-1α  
improves mitochondrial biogenesis and fatty acid 
oxidation in healthy and insulin-resistant skeletal muscle. 
It has been reported that PGC-1α is involved in the 
coordinated regulation of nuclear- and mitochondrial-
encoded genes required for contractile and metabolic 
adaptations in skeletal muscle (Puigserver & Spiegelman 
2003, Scarpulla 2008, Wende et  al. 2007). Of note, 
PGC-1α expression per se is also regulated by PGC-1α 
via its interaction with MEF2 (Handschin et  al. 2003). 
Based on the above literature, we believe that increased 
mitochondrial biogenesis in NE and EPI cells in HF rats 
is due to increased expression of PGC-1α (Karamanlidis 
et al. 2010, Ahuja et al. 2013). Decreased mitochondrial 
area and diameter without any change in mitochondrial 
volume density are indicative of more but smaller 
mitochondria in HF rats. Cellular respiration takes place in 
the mitochondrial cristae where biochemical energy from 
nutrients is converted into ATP, the energy currency of 
the cell. In response to increased energy demand, cristae 
increase its surface area by increasing cristae lumen width 
to produce more ATP. Thus, dilated cristae in HF rats 
are consistent with increased ATP production required 
for increased LDCV priming and consequent exocytosis 
(Rettig & Neher 2002).
 Heart switches from less energetically efficient 
fatty acids substrate to more energetically efficient 
carbohydrate substrate for ATP production to protect the 
myocardium under ischemic conditions (Neubauer 2007, 
Aragones et  al. 2009). Similar metabolic switch for ATP 
production also takes place in cancer cells (Vander Heiden 
et al. 2009). Therefore, increased glycogen content in the 
chromaffin cells of the adrenal medulla from the rats 
with HF may indicate a metabolic switch from fatty acid 
to carbohydrate metabolism to counteract HF-induced 
prolonged synthesis and release of catecholamines by the 
chromaffin cells.
 In summary, the adrenal medulla is activated during 
the chronic HF condition. These electron micrographic 
observation indicates that the chronic HF condition 
provokes increased basal SDCV (possibly containing 
PACAP and VIP) in splanchnic–adrenal synapse of HF 
rats promoting toward the maintenance of long-term 
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catecholamine secretion, increased ER and Golgi lumen 
width to accommodate the enhanced demand for 
increased catecholamine synthesis and release, and more 
mitochondria with dilated cristae and glycogen to adapt to 
the increased energy demand for the increased biogenesis 
and exocytosis of catecholamines from the adrenal 
medulla. Thus, although centrally mediated sympathetic 
activation accompanies chronic HF, the results in this 
study demonstrates heterogeneity of adaptive changes 
within the adrenal chromaffin cells that likely contribute 
to the functional consequences of chronic elevations in 
plasma catecholamines in pathophysiological state of 
chronic HF.
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